Interestingly, this deletion of CISH, which encodes the protein CIS—a known negative regulator of NK cell activity—aimed to enhance the anti-tumor efficacy of NK cells against glioblastoma (GBM), a highly aggressive brain tumor [186]. The gene discussed is CISH; the disease is neoplasm.